表紙:神経修復・再生の市場規模、シェア、動向分析レポート:製品別(生体材料、神経刺激・神経調節デバイス)、手術別、地域別、セグメント別予測、2022年~2030年
市場調査レポート
商品コード
1076453

神経修復・再生の市場規模、シェア、動向分析レポート:製品別(生体材料、神経刺激・神経調節デバイス)、手術別、地域別、セグメント別予測、2022年~2030年

Nerve Repair And Regeneration Market Size, Share & Trends Analysis Report By Product (Biomaterials, Neurostimulation & Neuromodulation Devices), By Surgery, By Region, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
神経修復・再生の市場規模、シェア、動向分析レポート:製品別(生体材料、神経刺激・神経調節デバイス)、手術別、地域別、セグメント別予測、2022年~2030年
出版日: 2022年04月18日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経修復・再生市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の神経修復・再生市場規模は2030年までに205億米ドルに達すると予測されています。

2022年から2030年までCAGR12.16%で拡大する見込みです。神経障害の発生率の増加や、神経障害に関する意識の高まりによる神経障害治療への需要が、市場を牽引します。さらに、政府の資金援助と償還政策、途切れることのない技術的進歩が市場成長を後押しすると予測されます。

2016年1月、EU Horizon 2020プログラムは、NUI Galwayの再生医療研究所(REMEDI)が立ち上げた研究プロジェクト「Autostem」(約673万米ドル)に資金を提供しました。このプロジェクトは、従来の技術よりも優れたロボットによる幹細胞生産工場を開発するものです。この技術は、がん、糖尿病、関節炎など、さまざまな病気の新しい治療法として期待されています。また、新興国の主要企業による研究開発や投資の増加も市場を牽引しています。2018年7月、Stem Cells Australia(SCA)は、Medical Research Future Fund(MRFF)から幹細胞研究のために300万米ドルを受け取りました。

また、脳性麻痺に対する臍帯血注入による幹細胞(フェーズII)や、ヒトの末梢神経損傷を修復するための軸索融合技術を促進するポリエチレングリコール(PEG)薬剤の使用(フェーズI)など、異なる神経疾患に対する安全かつ有効な治療法を開発すべく、政府や民間資金提供団体が臨床試験を行っています。

さらに、2017年10月、ストライカー・コーポレーションは、フランスの医療機器会社であるVEXIMを買収しました。VEXIM社のポートフォリオは、ストライカーのインターベンショナル・スパイン(IVS)ポートフォリオを補完するものです。この買収により、ストライカーは東欧、中東、アジア、ラテンアメリカの販売チャネルを強化します。2018年1月、ボストン・サイエンティフィック株式会社は、最初で唯一の脊髄刺激装置システム「Spectra WaveWriter」の米FDA承認を取得しました。本システムは、知覚障害に基づく治療に使用されます。

神経修復・再生市場レポートハイライト

  • 2021年には、中枢神経系(CNS)障害の症例が増加し、精神障害や利用可能な治療法に関する意識が高まったことから、神経調節・神経刺激装置製品セグメントが市場を牽引した
  • 生体材料製品セグメントは、脊髄の安定化と骨折の治癒を強化し、入院を減らすのに役立つ生分解性ポリマーの技術的進歩や開発により、予測期間中に最も速いCAGRで拡大すると予測される
  • 2021年には、技術的進歩と新しいデバイスの出現により、北米が市場をリードしました。政府の取り組みや資金提供、脊髄や脳の損傷などCNSの損傷事例の増加が、この地域の市場成長の主な理由となっています。
  • アジア太平洋地域は、予測期間中に最も急速に成長する地域市場であると予想されます。老年人口の増加、技術の進歩、多くのアンメット・メディカル・ニーズが、この地域の市場を牽引する要因の一つとなっています。
  • ペプチドのカクテル、神経刺激技術、幹細胞の脳への注入など、患者を昏睡状態から回復させることに成功した技術を組み合わせた治療法が使用されることになりました。
  • 既存の医療機器と再生生物学的製剤を組み合わせた複合的な取り組み

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析(モデル1)
    • 出来高価格分析(モデル2)
  • 二次情報一覧
  • 略語一覧
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し

第3章 市場変数、動向、範囲

  • 市場系列の見通し
    • 親市場の見通し
  • 市場セグメンテーション
  • 浸透と成長の見通しのマッピング
    • 浸透と成長の見通しのマッピング
  • 規制の枠組みと償還のシナリオ
  • 市場力学
    • 市場促進要因分析
      • 政府の資金と払い戻しの増加
      • 神経疾患の発生率の増加
      • 医療ツーリズムの台頭
    • 市場制約分析
      • 神経の修復と再生の治療に対する患者の意識の欠如
      • 治療費が高く、訓練を受けた医療従事者が利用できない
  • ビジネス環境分析ツール
    • ポーターのファイブフォース分析
      • 買い手の交渉力:普通
      • 供給企業の交渉力:低い
      • 競争企業間の敵対関係:高い
      • 新規参入業者の脅威:中程度
      • 代替品の脅威:中程度
    • PESTEL分析
      • 政治と法律の情勢
      • 経済情勢
      • 社会情勢
      • 技術情勢
      • 環境情勢
  • 主要取引と戦略的提携分析
    • 合併と買収
    • ライセンシングとパートナーシップ

第4章 神経修復および再生市場:製品分析

  • 神経修復および再生製品の市場シェア分析、2021年
  • 神経修復および再生製品市場:セグメントダッシュボード:
  • 製品セグメントの市場規模と予測、トレンド分析、2018年から2030年
    • バイオシミラー
    • 神経刺激および神経調節デバイス

第5章 神経修復および再生市場:手術分析

  • 神経修復および再生手術の市場シェア分析、2021年
  • 神経修復および再生手術市場:セグメントダッシュボード
  • 市場規模と予測、トレンド分析、2018年から2030年までの外科手術
    • 直接神経修復/神経外科
    • 神経移植
    • 幹細胞療法
    • 神経刺激および神経調節手術

第6章 神経修復および再生市場:地域分析

  • 神経修復および再生の地域市場シェア分析、2021年
  • 神経修復および再生地域市場:セグメントダッシュボード
  • 地域市場のスナップショット(市場規模、 CAGR、トップバーティカル、キープレーヤー、トップ動向)
  • 地域レベルのプレーヤーのリスト
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
  • 要因別SWOT分析(政治と法律、経済と技術)
    • 北米
      • 米国
      • カナダ
  • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
  • アジア太平洋地域
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
  • ラテンアメリカ
      • ブラジル
      • メキシコ
      • コロンビア
  • 中東とアフリカ
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ

第7章 競合分析

  • 主要な市場参加者別最近の動向と影響分析
  • 戦略的フレームワーク/競合の分類(主要なイノベーター、マーケットリーダー、新興プレーヤー
  • ベンダー情勢
  • 公開会社
    • 企業の市況分析(収益、地理的プレゼンス、製品ポートフォリオ、戦略的イニシアチブ、従業員の強み)
  • プライベートカンパニー
    • 企業の市況分析(地理的プレゼンス、製品ポートフォリオ、主要な提携、業界経験)
  • 企業プロファイル
    • CYBERONICS, INC.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • MEDTRONIC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • STRYKER
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • AXOGEN CORPORATION
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • ST. JUDE MEDICAL
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • BAXTER
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • BOSTON SCIENTIFIC CORPORATION
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
    • POLYGANICS
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • INTEGRA LIFESCIENCES
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
      • SWOT分析
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviation
  • Table 3 List of players in North America
  • Table 4 List of players in Europe
  • Table 5 List of players in Asia Pacific
  • Table 6 List of players in Latin America
  • Table 7 List of players in MEA
  • Table 8 North America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 11 North America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 12 U.S. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 13 U.S. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 14 U.S. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 15 Canada. nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada. nerve repair and regeneration market, by neurostimulation and neuromodulation devices 2018 - 2030 (USD Million)
  • Table 17 Canada nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 18 Europe nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
  • Table 19 Europe nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 20 Europe nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 21 Europe nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 22 U.K. nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 23 U.K. nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 24 U.K. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 25 Germany nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 27 Germany nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 28 France nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 29 France nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 30 France nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 31 Italy nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 32 Italy nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 33 Italy nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
  • Table 34 Spain nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 35 Spain nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 36 Spain nerve repair and regeneration Market, by surgery, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 41 Japan nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 42 Japan nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 43 Japan nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 44 China nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 45 China nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 46 China nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 47 India nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 48 India nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 49 India nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 50 Australia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 51 Australia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 52 Australia nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 53 South Korea nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 54 South Korea nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 55 South Korea nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 56 Latin America nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
  • Table 57 Latin America nerve repair and regeneration market, by product, 2018 - 2030 (USD Million)
  • Table 58 Latin America nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 59 Latin America nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 60 Brazil nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 61 Brazil nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 62 Brazil. nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 63 Mexico nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 64 Mexico nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 65 Mexico nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 66 Colombia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 67 Colombia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 68 Colombia nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 69 MEA nerve repair and regeneration market, by country, 2018 - 2030 (USD Million)
  • Table 70 MEA nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 71 MEA nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 72 MEA nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 73 South Africa nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 74 South Africa nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 75 South Africa nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 76 UAE nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 77 UAE nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 78 UAE nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia nerve repair and regeneration market, by product 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia nerve repair and regeneration market, by neurostimulation and neuromodulation devices, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia. Nerve repair and regeneration market, by surgery, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market outlook
  • Fig. 9 Nerve repair and regeneration market segmentation
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 PORTER'S five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Nerve repair and regeneration product market share analysis, 2021
  • Fig. 17 Nerve repair and regeneration product market: Segment dashboard
  • Fig. 18 Biosimilars nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 19 Neurostimulation and neuromodulation devices nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 20 Nerve repair and regeneration surgery market share analysis, 2021
  • Fig. 21 Nerve repair and regeneration surgery market: Segment dashboard
  • Fig. 22 Direct nerve repair/Neurorrhaphy market, 2018 - 2030 (USD Million)
  • Fig. 23 Nerve grafting market, 2018 - 2030 (USD Million)
  • Fig. 24 Stem cell therapy market, 2018 - 2030 (USD Million)
  • Fig. 25 Neurostimulation and neuromodulation surgeries market, 2018 - 2030 (USD Million)
  • Fig. 26 Nerve repair and regeneration regional market share analysis, 2021
  • Fig. 27 Nerve repair and regeneration regional market: Segment dashboard
  • Fig. 28 Nerve repair and regeneration market place: Key takeaways
  • Fig. 29 North America Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 33 U.K. Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 35 France Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 40 China Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 41 India Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 47 Colombia Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 48 MEA Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 50 UAE Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Nerve repair and regeneration market, 2018 - 2030 (USD Million)
  • Fig. 52 Strategy framework
  • Fig. 53 Strategy framework / Competition categorization
  • Fig. 54 Strategy mapping
  • Fig. 55 Company market position analysis (revenue, geographic presence, product portfolio, strategic initiatives, employee strength)
  • Fig. 56 Company market position analysis (geographic presence, product portfolio, key alliance, industry experienc
目次
Product Code: 978-1-68038-961-6

Nerve Repair And Regeneration Market Growth & Trends:

The global nerve repair and regeneration market size is expected to reach USD 20.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.16% from 2022 to 2030. Demand for neurological disorder therapies owing to the increasing incidence and rising awareness regarding the same will drive the market. Moreover, government funding and reimbursement policies and uninterrupted technological advances are projected to boost market growth.

In January 2016, the EU Horizon 2020 program funded a research project 'Autostem', launched by the NUI Galway's Regenerative Medicine Institute (REMEDI), costing about USD 6.73 million. This project was to develop a robotic stem cell production factory, having an edge over the old traditional techniques. This technique offers prospects for new therapies for a range of diseases, such as cancers, diabetes, and arthritis. Increased R&D and investments by key companies in emerging countries are also driving the market. In July 2018, Stem Cells Australia (SCA) received USD 3 million for stem cell research from the Medical Research Future Fund (MRFF).

In addition, government and private funded organizations are conducting clinical trials to develop a safe and effective therapy for different neurological disorders, such as Stem Cells in Umbilical Blood Infusion for Cerebral Palsy (Phase II) and the usage of Polyethylene glycol (PEG) drug (Phase I) to promote axonal fusion technique to repair peripheral nerve injuries in humans.

Furthermore, in October 2017, Stryker Corporation acquired VEXIM, a France-based medical device company. VEXIM's portfolio is complementary to Stryker's Interventional Spine (IVS) portfolio. With this acquisition, Stryker will strengthen its distribution channels in Eastern Europe, the Middle East, Asia, and Latin America. In January 2018, Boston Scientific Corporation received U.S. FDA approval for the first and only Spectra WaveWriter spinal cord stimulator system. This system is used for paresthesia-based therapy.

Nerve Repair And Regeneration Market Report Highlights:

  • In 2021, the neuromodulation and neurostimulation devices product segment led the market due to the increased cases of Central Nervous System (CNS) disorders and awareness regarding mental disorders and available treatments
  • The biomaterials product segment is anticipated to expand at the fastest CAGR during the forecast period due to technological advancements and the development of biodegradable polymers that can help enhance spinal stabilization and healing of fractures and reduce hospitalization
  • North America led the market in 2021 owing to technological advancements and the advent of new devices. Government initiatives and funding and increased cases of injured CNS, such as injuries to the spinal cord and brain, were some of the major reasons responsible for the regional market growth
  • Asia Pacific is expected to be the fastest-growing regional market during the forecast period. The growing geriatric population, technological advancements, and many unmet medical needs are some of the factors driving the regional market
  • The combination of therapies including a cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells, and other techniques that were successful in bringing patients out of coma were to be used
  • Existing medical devices were combined with regenerative biological medicines with the objective to achieve such a complex initiative

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2

Chapter 2. Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3. Market Variables, Trends & Scope

  • 3.1 Market Lineage outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
    • 3.3.1 Penetration & Growth Prospect Mapping
  • 3.4 Regulatory Framework & Reimbursement Scenario
  • 3.5 Market Dynamics
    • 3.5.1 Market Driver Analysis
      • 3.5.1.1 Increasing government fundings and reimbursements
      • 3.5.1.2 Increasing incidences of the neurological disorders
      • 3.5.1.3 Rising medical tourism
    • 3.5.2 Market Restraint Analysis
      • 3.5.2.1 Lack of awareness in the patients for treatment of nerve repair and regeneration
      • 3.5.2.2 High cost of the treatment and unavailability of trained medical personnel
  • 3.6 Business Environment Analysis Tools
    • 3.6.1 Porter's Five Forces Analysis
      • 3.6.1.1 Bargaining power of buyers: Moderate
      • 3.6.1.2 Bargaining power of suppliers: Low
      • 3.6.1.3 Competitive rivalry: High
      • 3.6.1.4 Threat of new entrants: Moderate
      • 3.6.1.5 Threat of substitutes: Moderate
    • 3.6.2 PESTEL Analysis
      • 3.6.2.1 Political & legal landscape
      • 3.6.2.2 Economic landscape
      • 3.6.2.3 Social landscape
      • 3.6.2.4 Technological landscape
      • 3.6.2.5 Environmental landscape
  • 3.7 Major Deals & Strategic Alliances Analysis
    • 3.7.1 Mergers & Acquisitions
    • 3.7.2 Licensing & Partnership

Chapter 4. Nerve Repair And Regeneration Market: Product Analysis

  • 4.1 Nerve Repair And Regeneration Product Market Share Analysis, 2021
  • 4.2 Nerve Repair And Regeneration Product Market: Segment Dashboard:
  • 4.3 Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Product Segment
    • 4.3.1 Biosimilars
      • 4.3.1.1 Biosimilars market, 2018 - 2030 (USD Million)
    • 4.3.2 Neurostimulation & Neuromodulation Devices
      • 4.3.2.1 Spinal cord stimulation devices market, 2018 - 2030 (USD Million)
      • 4.3.2.2. Deep brain stimulation devices market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Sacral nerve stimulation devices market, 2018 - 2030 (USD Million)
      • 4.3.2.4 Vagus nerve stimulation devices market, 2018 - 2030 (USD Million)
      • 4.3.2.5 Gastric electric stimulation devices market, 2018 - 2030 (USD Million)

Chapter 5. Nerve Repair And Regeneration Market: Surgery Analysis

  • 5.1 Nerve Repair And Regeneration Surgery Market Share Analysis, 2021
  • 5.2 Nerve Repair And Regeneration Surgery Market: Segment Dashboard
  • 5.3 Market Size & Forecasts And Trend Analyses, 2018 - 2030 For The Surgery
    • 5.3.1 Direct Nerve Repair/Neurorrhaphy
      • 5.3.1.1 Direct nerve repair/Neurorrhaphy market, 2018 - 2030 (USD Million)
    • 5.3.2 Nerve Grafting
      • 5.3.2.1 Nerve grafting market, 2018 - 2030 (USD Million)
    • 5.3.3 Stem Cell Therapy
      • 5.3.3.1 Stem cell therapy market, 2018 - 2030 (USD Million)
    • 5.3.4 Neurostimulation & Neuromodulation Surgeries
      • 5.3.4.1 Neurostimulation & neuromodulation surgeries market, 2018 - 2030 (USD Million)

Chapter 6. Nerve Repair And Regeneration Market: Regional Analysis

  • 6.1 Nerve Repair And Regeneration Regional Market Share Analysis, 2021
  • 6.2 Nerve Repair And Regeneration Regional Market: Segment Dashboard
  • 6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 6.4 List of Players at Regional Level
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
  • 6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 6.6 Market Size, & Forecasts, And Trend Analysis, 2018 - 2030
    • 6.6.1 North America
    • 6.6.2 North America Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
      • 6.6.2.1 U.S.
      • 6.6.2.2 Canada
  • 6.7 Europe
    • 6.7.1 Europe Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
      • 6.7.1.1 U.K.
      • 6.7.1.2. Germany
      • 6.7.1.3 France
      • 6.7.1.4. Italy
      • 6.7.1.5 Spain
  • 6.8 Asia Pacific
    • 6.8.1 Asia Pacific Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
      • 6.8.1.1 Japan
      • 6.8.1.2 China
      • 6.8.1.3 India
      • 6.8.1.4 Australia
      • 6.8.1.5 South Korea
  • 6.9 Latin America
    • 6.9.1 Latin America Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
      • 6.9.1.1 Brazil
      • 6.9.1.2 Mexico
      • 6.9.1.3 Colombia
  • 6.10 Middle East and Africa
    • 6.10.1 MEA Nerve Repair And Regeneration Market, 2018 - 2030 (USD Million)
      • 6.10.1.1 UAE
      • 6.10.1.2 Saudi Arabia
      • 6.10.1.3 South Africa

Chapter 7. Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players
  • 7.3 Vendor Landscape
  • 7.4 Public Companies
    • 7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
  • 7.5 Private Companies
    • 7.5.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
  • 7.6 Company Profiles
    • 7.6.1 CYBERONICS, INC.
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
      • 7.6.1.5 SWOT Analysis
    • 7.6.2 MEDTRONIC
      • 7.6.2.1 Company overview
      • 7.6.2.2 Financial performance
      • 7.6.2.3 Product benchmarking
      • 7.6.2.4 Strategic initiatives
      • 7.6.2.5 SWOT Analysis
    • 7.6.3 STRYKER
      • 7.6.3.1 Company overview
      • 7.6.3.2 Financial performance
      • 7.6.3.3 Product benchmarking
      • 7.6.3.4 Strategic initiatives
      • 7.6.3.5 SWOT Analysis
    • 7.6.4 AXOGEN CORPORATION
      • 7.6.4.1 Company overview
      • 7.6.4.2 Financial performance
      • 7.6.4.3 Product benchmarking
      • 7.6.4.4 Strategic initiatives
      • 7.6.4.5 SWOT Analysis
    • 7.6.5 ST. JUDE MEDICAL
      • 7.6.5.1 Company overview
      • 7.6.5.2 Financial performance
      • 7.6.5.3 Product benchmarking
      • 7.6.5.4 Strategic initiatives
      • 7.6.5.5 SWOT Analysis
    • 7.6.6 BAXTER
      • 7.6.6.1 Company overview
      • 7.6.6.2 Financial performance
      • 7.6.6.3 Product benchmarking
      • 7.6.6.4 Strategic initiatives
      • 7.6.6.5 SWOT Analysis
    • 7.6.7 BOSTON SCIENTIFIC CORPORATION
      • 7.6.7.1 Company overview
      • 7.6.7.2 Financial performance
      • 7.6.7.3 Product benchmarking
      • 7.6.7.4 Strategic initiatives
      • 7.6.7.5 SWOT Analysis
    • 7.6.8 POLYGANICS
      • 7.6.8.1 Company overview
      • 7.6.8.2 Financial performance
      • 7.6.8.3 Product benchmarking
      • 7.6.8.4 Strategic initiatives
    • 7.6.9 INTEGRA LIFESCIENCES
      • 7.6.9.1 Company overview
      • 7.6.9.2 Financial performance
      • 7.6.9.3 Product benchmarking
      • 7.6.9.4 Strategic initiatives
      • 7.6.9.5 SWOT Analysis